1. Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023. Issue 1 (18th November 2021) Authors: Shoji, Tadahiro; Enomoto, Takayuki; Abe, Masakazu; Okamoto, Aikou; Nagasawa, Takayuki; Oishi, Tetsuro; Nagase, Satoru; Mori, Masahiko; Inokuchi, Yuki; Kamiura, Shoji; Komiyama, Shinichi; Takeshima, Nobuhiro; Sugiyama, Toru Journal: Cancer science Issue: Volume 113:Issue 1(2022) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗